Seventh Sense Biosystems Inc. news
YourBio Health, formerly Seventh Sense Biosystems, Inc., developers of the world’s first push-button blood collection device, announced the launch of its website where UK consumers can order a convenient, easy to use, nearly painless and accurate COVID-19 antibody test.
“We’re happy to launch our COVID-19 antibody test service to UK consumers today,” said Stephen Hahn, Chief Medical Officer (Interim). “At a time when monitoring COVID-19 and immune r
YourBio Health, Inc., developers of the world’s first painless push-button blood collection device, announced today that Stephen Hahn, M.D. joins as interim Chief Medical Officer; he also serves as the Chief Medical Officer, for the Preemptive Medicine and Health Security initiative at Flagship Pioneering at-large. Dr. Hahn previously served as the U.S. Food and Drug Administration Commissioner from 2019–2021.
Prior to joining the FDA, he served as Chief Medical Executive
Seventh Sense Biosystems, Inc., developers of the world’s first painless push-button blood collection device, announced today its new corporate name, YourBio Health, Inc., which reflects the company’s focus on putting health information in the hands of the individual. YourBio Health enables individuals to collect a blood sample and receive the results via a secure website from the convenience of home. This easy, painless method allows greater access to and control of one’s p
Making blood collection simpler, more convenient, and more comfortable. That’s our mission, and we are thrilled to share that our partner, Gateway Genomics, is leveraging our TAP II blood collection technology in its product offering, the SneakPeek Early Gender DNA Test. Called SneakPeek Snap, the blood collection device is included as part of the SneakPeek at-home blood collection kit.
Early feedback from users shows they are excitedly on board with a better way to collect bloo
Our customer HumanPeople, a UK based personalized health company, announced plans to enhance their service by integrating TAP II, following our recent CE Mark.
We are thrilled to see TAP II, the blood collection product we designed, solving probl